Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
Real-time Estimate Cboe BZX  -  02:59 2022-10-05 pm EDT
49.04 USD   +3.25%
10/04Insider Sell: Harmony Biosciences Holdings
MT
10/03Harmony Biosciences Holdings, Inc. : Other Events (form 8-K)
AQ
09/28HARMONY BIOSCIENCES HOLDINGS, INC. Submission of Matters to a Vote of Security Holders (form 8-K/A)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Harmony Biosciences Holdings

08/11/2022 | 10:09am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
HARMONY BIOSCIENCES HOLDINGS, INC. 3.24% 48.83 Delayed Quote.11.37%
HBM HEALTHCARE INVESTMENTS AG -0.42% 236 Delayed Quote.-30.09%
All news about HARMONY BIOSCIENCES HOLDINGS, INC.
10/04Insider Sell: Harmony Biosciences Holdings
MT
10/03Harmony Biosciences Holdings, Inc. : Other Events (form 8-K)
AQ
09/28HARMONY BIOSCIENCES HOLDINGS, INC. Submission of Matters to a Vote of Security Holders..
AQ
08/23Insider Sell: Harmony Biosciences Holdings
MT
08/17Harmony biosciences to participate in upcoming investor conferences
PR
08/16Insider Sell: Harmony Biosciences Holdings
MT
08/11Insider Sell: Harmony Biosciences Holdings
MT
08/11Reuters-schedule/…
RE
08/10Reuters-schedule/…
RE
08/09Insider Sell: Harmony Biosciences Holdings
MT
More news
Analyst Recommendations on HARMONY BIOSCIENCES HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2022 430 M - -
Net income 2022 83,5 M - -
Net cash 2022 148 M - -
P/E ratio 2022 34,4x
Yield 2022 -
Capitalization 2 810 M 2 810 M -
EV / Sales 2022 6,19x
EV / Sales 2023 4,06x
Nbr of Employees 180
Free-Float 80,1%
Chart HARMONY BIOSCIENCES HOLDINGS, INC.
Duration : Period :
Harmony Biosciences Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HARMONY BIOSCIENCES HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 47,49 $
Average target price 61,50 $
Spread / Average Target 29,5%
EPS Revisions
Managers and Directors
John C.s Jacobs President, Chief Executive Officer & Director
Sandipkumar S. Kapadia Chief Financial Officer
Jeffrey S. Aronin Non-Executive Chairman
Jeffrey M. Dayno Chief Medical Officer
David Bradshaw Head-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
HARMONY BIOSCIENCES HOLDINGS, INC.11.37%2 810
JOHNSON & JOHNSON-3.19%435 445
ELI LILLY AND COMPANY16.41%313 453
ROCHE HOLDING AG-12.23%279 092
ABBVIE INC.4.87%251 052
PFIZER, INC.-24.71%249 525